A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …

Background Patients with inflammatory bowel disease (IBD) and healthy controls received
primary SARS-CoV-2-mRNA vaccination and a booster after six months. Anti-TNF-α-treated …

Background Some patients with inflammatory bowel disease (IBD) on immunosuppressive
therapies may have a blunted response to certain vaccines, including the messenger RNA …

Alimentary tract inflammation in inflammatory bowel disease (IBD) is treated by systemically
administered drugs that alter fundamental host immune responses. Biologics that target …

Epitopes recognized by T cells are a collection of short peptide fragments derived from
specific antigens or proteins. Immunological research to study T cell responses is hindered …

Background Beyond systematic reviews and meta-analyses, there have been no direct
studies of serological response to COVID-19 in patients with inflammatory bowel disease …

Abstract SARS-CoV-2-specific CD8+ T cells recognize conserved viral peptides and in the
absence of cross-reactive antibodies form an important line of protection against emerging …

Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection
causes coronavirus disease 2019 (COVID‐19), which is still devastating economies and …

Title: Impact of SARS-CoV-2 vaccination in inflammatory bowel disease patients with
different biological agents: a systematic re Page 1 Title: Impact of SARS-CoV-2 vaccination …